» Articles » PMID: 18359082

Distinctive IgVH Gene Segments Usage and Mutation Status in Chinese Patients with Chronic Lymphocytic Leukemia

Overview
Journal Leuk Res
Date 2008 Mar 25
PMID 18359082
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: The incidence of chronic lymphocytic leukemia (CLL) in Asian countries is lower than that in the Western ones, where CLL is the most common leukemia. It is a clinically heterogeneous disease, with survival ranging from a few months to decades. The mutation status of the immunoglobulin variable heavy chain (IgVH) gene has significantly improved prediction of the risk for disease progression. We investigated the frequency and mutation status of IgVH gene expression in Chinese patients with CLL.

Methods: IgVH gene segments usage and mutation status were investigated by multiplex RT-PCR, and the relationship between IgVH somatic mutation status and the expression of CD38 and ZAP-70 was analyzed in 65 CLL patients.

Results: Forty-five (69.2%) patients had mutated IgVH, and 20 (30.8%) had unmutated IgVH. The most frequently expressed VH gene family was found to be VH3 (47.7%) followed by VH4 (40%), VH1 (6.2%), VH2 (4.6%) and VH7 (1.5%), with no expression of VH5 or VH6 gene families. VH1-69 and VH3-21 which commonly overused in Western CLL were very low in our cohort. IgVH gene mutation status was significantly associated with the expression of CD38.

Conclusions: The frequency of IgVH gene families indicates significant difference in Chinese CLL patients compared with Western patients, suggesting involvement of ethnic and/or environmental factors in CLL disease initiation. The expression of them may be simple and reliable surrogates for the identification of IgVH mutations.

Citing Articles

Characteristics of chronic lymphocytic leukemia in Japan: Comprehensive analysis of the CLLRSG-01 study.

Takizawa J, Suzuki R, Izutsu K, Kiguchi T, Asaoku H, Saburi Y Int J Hematol. 2024; 119(6):686-696.

PMID: 38492198 DOI: 10.1007/s12185-024-03741-z.


Association of Cytogenetics Aberrations and Mutations with Outcome in Chronic Lymphocytic Leukemia Patients in a Real-World Clinical Setting.

Munoz-Novas C, Gonzalez-Gascon-Y-Marin I, Figueroa I, Sanchez-Paz L, Perez-Carretero C, Quijada-Alamo M Glob Med Genet. 2024; 11(1):59-68.

PMID: 38348157 PMC: 10861322. DOI: 10.1055/s-0044-1779668.


Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia.

Gao R, Du K, Liang J, Xia Y, Wu J, Li Y Int J Mol Sci. 2023; 24(8).

PMID: 37108556 PMC: 10138885. DOI: 10.3390/ijms24087396.


-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients.

Mu Y, Fan X, Chen T, Meng Y, Lin J, Yuan J J Clin Med. 2023; 12(7).

PMID: 37048750 PMC: 10094974. DOI: 10.3390/jcm12072667.


[Distinguish immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Chinese patients with chronic lymphocytic leukemia].

Li H, Wang T, Yin Y, Wang P, Cheng Z, Li J Zhonghua Xue Ye Xue Za Zhi. 2022; 42(12):1025-1029.

PMID: 35045675 PMC: 8770890. DOI: 10.3760/cma.j.issn.0253-2727.2021.12.011.